Brent Hahn is an entrepreneur and drug delivery executive with nearly three decades of experience commercializing innovative medical technologies. As co-founder and CEO of Gram Medical, he is leading the development of a patented oral drug delivery platform designed for protected and targeted small intestine delivery with increased bioavailability. Over the past 30 years, Hahn has built a career at the intersection of engineering, manufacturing, and commercialization, helping transform innovative medical concepts into successful and sustainable products. His expertise spans miniaturization, precision manufacturing, advanced materials, and drug delivery, with leadership roles that have contributed to more than $1 billion in sales to medical and drug delivery OEMs. Prior to co-founding Gram Medical, Hahn served in executive leadership roles, including as CEO of Isometric Micro Molding during its acquisition, where he helped scale organizations and commercialize highly engineered medical technologies. Hahn holds a degree in Plastics Engineering and an MBA, bringing together technical depth with strategic business leadership.